Spanish authorities rule out any link to vaccine in death of teacher who received jab

The woman suffered a brain haemorrhage, according to an autopsy

A health worker holds the hand of a woman before being vaccinated in Madrid (AP)

The death of a Spanish teacher had no connection with the AstraZeneca vaccination she received ten days earlier, a preliminary autopsy has found. 

Pilar González Bres, 43, a mother-of-two, died on March 13 after suffering a brain haemorrhage.  

An autopsy indicated that her death was caused by an aneurysm, which is the rupture of a blood vessel in the brain, which caused the haemorraghe.  

Tests showed that the maths teacher had a predisposition to suffering a cerebrovascular incident. 

The preliminary autopsy showed that no signs of thrombosis were detected but further tests will have to be carried out.

Health authorities in Spain had launched an  investigation after the death of Ms González,  who complained of suffering from headaches after receiving the vaccination on March 3 and went to a hospital.  

Read more:

• Why are countries suspending AstraZeneca vaccine rollouts? 
• UK medicines regulator insists AstraZeneca vaccine safe to use
• Some UK patients starting to reject AstraZeneca vaccine, GPs warn

Doctors initially attributed her headaches to the normal side effects associated with the vaccine. 

The woman returned to the hospital in Marbella in southern Spain on March 13 but specialists did not at first detect any serious problem.  

Four hours later, a scan revealed fluid accumulation on the brain and she was operated on immediately.  She died shortly afterwards.

Nearly a dozen countries resumed use of AstraZeneca’s COVID-19 shots on Friday as EU and British regulators said the benefits outweighed any risks after reports of rareinstances of blood clotting that temporarily halted inoculations.

The end of vaccine suspensions will be a key test of public confidence in the vaccine and drug regulators conclusions as the virus variants spread and the global death toll, now at nearly 2.7 million, rises.